BioSpace News Archive

IntegriChain, delivering pharma’s only comprehensive data, consulting, and business process platform for market access, announced that Gross-to-Net and Life Sciences accounting expert Jen Sharpe will present at Informa’s upcoming Life Sciences Accounting and Reporting Conference.

Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2021 Annual and Special Meeting of Shareholders held March 9th, 2022.

Servier, a global pharmaceutical company, today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for TIBSOVO® (ivosidenib tablets) for two indications as a first line treatment, in combination with azacitidine, in patients with previously untreated IDH1-mutated acute myeloid leukemia (AML) and not eligible for intensive chemotherapy, as well as in previously treated, locally advanced or metastatic IDH1-mutated cholangiocarcinoma.

Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, today announced the appointments of Arash Yavari, M.B.B.S., DPhil., M.R.C.P., as chief scientific officer, Hugo Fry as chief commercial officer and Komal Joshi as chief financial officer.

Paragon 28, Inc. announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting at the Canaccord Genuity Musculoskeletal Conference on March 22nd and 2022 Needham Healthcare Conference on April 11th.

Atalanta Therapeutics today announced the appointment of Alfred W. Sandrock, Jr., M.D., Ph.D. to the company’s Board of Directors.

Cyclo Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare Conference.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced updates from multiple early research and development (R&D) studies across its Click Neurobehavioral Intervention (CNI) Platform™.

Melt Pharmaceuticals, Inc. today announced the addition of Brad Osborne as Chief Financial Officer.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Thursday, March 24.